Skip to content
Screener

Total Current Liabilities at other companies

GPA
General Purpose Acquisition Corp.GPAC
$13.86M-38.7%
Veradermics logo
VeradermicsMANE
$6.72M
Polaryx Therapeutics, Inc. logo
Polaryx Therapeutics, Inc.PLYX
$1.01M
Dycom Industries logo
Dycom IndustriesDY
$1.15B+81.9%
Target logo
TargetTGT
$19.38B+2.1%
Dollar General logo
Dollar GeneralDG
$7.24B+13.1%

Where this comes from

Reported directly by First Tracks Biotherapeutics Inc in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.

Filed
May 14, 2026, 4:32 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224190
Line itemMarch 31, 2026December 31,2025
Accounts payable$7,496$3,111
Accrued expenses25,61625,832
Current portion of operating lease liability2,080
Total current liabilities33,11231,023
Operating lease liability, net of current portion12,032
Equity:
Net Parent Investment257,610287,514
Accumulated other comprehensive loss(146)(24)

Item 1. Combined Financial Statements.

FAQ

What is First Tracks Biotherapeutics Inc's total current liabilities?
First Tracks Biotherapeutics Inc (TRAX) reported total current liabilities of $33.11M in Q1 2026.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about First Tracks Biotherapeutics Inc's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude